Prof. Xiaochun Wan is the Deputy Director of the Institute of Biomedicine and Biotechnology, the Director of the Center for Protein and Cell-based Drugs, and the Director of the Guangdong immune cell therapy engineering and technology research center. He completed his Master's studies in Biochemistry at McGill University and his PhD studies in Immunology at the University of Montreal. His research area is biological medicine.
Dr. Dehong Yan is an Associate Professor at Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), and the principal investigator (PI) of the Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, SIAT, CAS. He is also a Ph.D. and Master's Instructor at the University of Chinese Academy of Sciences (UCAS). He received his PhD degree in Immunology from Sun Yat-sen University and was a Post-Doc fellow at Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. His research mainly focuses on The Biology of MDSCs in cancers, the study of the strategy of tumor immunotherapy targeting MDSC lipid metabolism, and the combination therapy of MDSC checkpoint blockade and other immunotherapies such as PD-1/PD-L1, CAR-T, and CAR-M.
